descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 2018 English Publisher:Elsevier BVJournal:Hematology/Oncology Clinics of North America, volume 32, pages 237-245 (issn: 0889-8588,

Authors: Taher, Ali T.; Cappellini, Maria Domenica; Bou-Fakhredin, Rayan; Coriu, Daniel; Musallam, Khaled M.;

doi: 10.1016/j.hoc.2017.11.001

pmid: 29458729

handle: 2434/555810

Hypercoagulability and Vascular Disease

- Summary
- Subjects
- Metrics

Abstract

The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.

Related Organizations

University of Milan
Italy
American University of Beirut Medical Center
Lebanon
Carol Davila University of Medicine and Pharmacy
Romania
American University of Beirut
Lebanon

Keywords

Disease Management, Humans, Thalassemia, Thrombophilia, Cerebrovascular disease; Hypercoagulable state; Pulmonary hypertension; Thrombosis; Hematology; Oncology, Vascular Diseases

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	29
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%